Bioventus Inc. (BVS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 8.93M | 37.97M | 30.1M | 25.94M | -19.33M | 19.32M | 10.32M | 15.16M | -6M | 10.37M | -8.31M | 10.79M |
| Operating CF Margin % | 6.76% | 24.05% | 21.71% | 17.57% | -15.61% | 12.58% | 7.42% | 10.03% | -4.64% | 7.66% | -6.88% | 7.88% |
| Operating CF Growth % | 146.22% | 96.5% | 191.76% | 71.07% | -221.92% | 86.25% | 224.06% | 40.45% | -341.16% | 97.83% | -1086.16% | 267.3% |
| Net Income | 3.11M | 17.32M | 3.15M | 9.27M | -3.32M | -318K | -5.42M | -23.99M | -4.57M | -6.1M | -8.79M | -4.73M |
| Depreciation & Amortization | 11.21M | 11.69M | 11.4M | 12.05M | 11.87M | 12.4M | 12.28M | 13.09M | 11.79M | 12.46M | 13.83M | 14.6M |
| Stock-Based Compensation | 0 | 3.44M | 0 | 3.64M | 2.41M | 1.73M | 2.06M | 3.67M | 2.59M | 0 | 1.83M | -2.73M |
| Deferred Taxes | 135K | -1.13M | 135K | 44K | 43K | 3.21M | -511K | -8.18M | 81K | 1.16M | 0 | -876K |
| Other Non-Cash Items | 4.66M | 440K | 4.73M | 453K | 870K | 4.4M | 2.37M | 25.03M | -1.14M | 867K | 1.03M | 1.55M |
| Working Capital Changes | -10.18M | 6.21M | 10.68M | 477K | -31.2M | -2.11M | -458K | 5.54M | -14.76M | 1.98M | -16.21M | 2.99M |
| Change in Receivables | 7.32M | 1.89M | 1.82M | -13.63M | 9M | -5.79M | 17.06M | 0 | -1.96M | -9.19M | 7.92M | 0 |
| Change in Inventory | -2.65M | 12.97M | 291K | -2.81M | -1.88M | -5.56M | -2.52M | 0 | -4.07M | 8.13M | -1.05M | 0 |
| Change in Payables | -15.37M | 0 | 7.31M | 0 | 0 | 0 | -21.33M | 0 | -7.33M | 5.79M | -25.83M | 0 |
| Cash from Investing | -574K | -580K | -473K | -1.37M | -826K | 24.1M | -64K | -77K | -1M | -591K | -2.04M | 33.5M |
| Capital Expenditures | -574K | -580K | -473K | -683K | -826K | -574K | 645K | -77K | -291K | -369K | -2.04M | -1.4M |
| CapEx % of Revenue | 0.43% | 0.37% | 0.34% | 0.46% | 0.67% | 0.37% | 0.46% | 0.05% | 0.22% | 0.27% | 1.69% | 1.02% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 24.68M | 0 | 0 | 0 | -222K | 0 | 34.9M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -686K | 0 | 0 | -709K | 0 | -709K | 0 | 0 | 0 |
| Cash from Financing | -23.14M | -28.45M | -19.98M | -14.66M | 947K | -42.85M | 362K | -7.84M | -4.24M | -14K | 8.23M | -62.25M |
| Debt Issued (Net) | -22M | -28.75M | -19.86M | -5M | 10M | -48.26M | 0 | -8.26M | -3.06M | 0 | 8M | -60.26M |
| Equity Issued (Net) | 120K | 511K | 96K | 1.32M | 150K | 1.1M | 553K | 609K | 177K | 158K | 397K | 139K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.26M | -208K | -216K | -10.98M | -9.2M | 4.31M | -191K | -190K | -1.36M | -172K | -168K | -2.12M |
| Net Change in Cash | -15.39M | 9.07M | 9.25M | 10.11M | -18.78M | -1.49M | 11.08M | 6.82M | -11.79M | 10.14M | -2.56M | -17.71M |
| Free Cash Flow | 8.36M | 37.39M | 29.63M | 25.25M | -20.16M | 18.75M | 10.25M | 15.09M | -6.3M | 10.01M | -10.35M | 9.4M |
| FCF Margin % | 6.33% | 23.68% | 21.37% | 17.1% | -16.27% | 12.2% | 7.38% | 9.98% | -4.86% | 7.39% | -8.57% | 6.86% |
| FCF Growth % | 141.47% | 99.42% | 188.97% | 67.42% | -220.16% | 87.39% | 199.04% | 60.51% | -488.41% | 443.45% | -340.47% | 933.88% |
| FCF per Share | 0.12 | 0.54 | 0.43 | 0.37 | -0.31 | 0.29 | 0.16 | 0.24 | -0.10 | 0.16 | -0.16 | 0.15 |
| FCF Conversion (FCF/Net Income) | 2.87x | 2.57x | 9.54x | 3.48x | 7.33x | -123.86x | -2.14x | -0.59x | 1.23x | -1.70x | 1.14x | -2.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |